CVS Health

ThoughtSpot Named Google Cloud Technology Partner of the Year for Data - Business Intelligence

Retrieved on: 
Tuesday, April 9, 2024

MOUNTAIN VIEW, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- ThoughtSpot , the AI-Powered Analytics company, today announced it has been named the 2024 Google Cloud Technology Partner of the Year Award for Data – Business Intelligence.

Key Points: 
  • MOUNTAIN VIEW, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- ThoughtSpot , the AI-Powered Analytics company, today announced it has been named the 2024 Google Cloud Technology Partner of the Year Award for Data – Business Intelligence.
  • With ThoughtSpot and Google Cloud, companies around the world are transforming data into actionable insights across their organization, maximizing the value of their cloud investments as they put GenAI to work for their business.
  • ThoughtSpot SaaS is available on Google Cloud Marketplace, the BigQuery Partner Center, and Google Workspace Marketplace.
  • "We're proud to announce ThoughtSpot as a 2024 Google Cloud Partner Award winner and recognize their achievements enabling customer success from the past year.”

ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights

Retrieved on: 
Thursday, March 21, 2024

WINSTON-SALEM, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced financial results for the year ended December 31, 2023.

Key Points: 
  • WINSTON-SALEM, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced financial results for the year ended December 31, 2023.
  • In November, the Company announced Dr. Bruce Culleton assumed the role of the CEO and joined the ProKidney board of directors.
  • Dr. Culleton joined ProKidney in July 2023 as Executive Vice President of Clinical Development and Commercialization.
  • Mr. Periera-Kamath had previously joined ProKidney in July 2023 as Vice President of Business Development & Innovative Solutions.

University of Phoenix Receives Arizona Veteran Supportive Campus Recertification

Retrieved on: 
Thursday, March 28, 2024

University of Phoenix is proud to share it has been recertified as an Arizona Veteran Supportive Campus by the Arizona Department of Veterans’ Services.

Key Points: 
  • University of Phoenix is proud to share it has been recertified as an Arizona Veteran Supportive Campus by the Arizona Department of Veterans’ Services.
  • “We are pleased to once again recognize University of Phoenix as a certified Arizona Veteran Supportive Campus for their commitment to supporting its student veterans, faculty and staff,” states Dana Allmond, Director, Arizona Department of Veterans’ Services.
  • “By instituting veterans’ programs, resources and awareness throughout the university, they are fostering a positive and educational experience for student veterans.”
    As a certified Arizona Veteran Supportive Campus , University of Phoenix met Arizona Department of Veterans’ Services C.A.R.E.
  • "In our ongoing efforts to support our student veterans, University of Phoenix proudly reaffirms its dedication to the standards established by the Arizona Department of Veterans’ Services," states Eric Ryan, Marine Corps veteran and senior director of Military Operations at University of Phoenix.

Mark Farrah Associates Reviewed Enrollment Mix and Financial Metrics for Leading Health Plans

Retrieved on: 
Wednesday, March 27, 2024

Mark Farrah Associates (MFA), www.markfarrah.com , reviewed final year-end 2022 enrollment mix and financial metrics for the top 5 health plans.

Key Points: 
  • Mark Farrah Associates (MFA), www.markfarrah.com , reviewed final year-end 2022 enrollment mix and financial metrics for the top 5 health plans.
  • UnitedHealth, Elevance Inc., CVS Health, Centene, and Health Care Service Corp. (HCSC) insured 43% Americans in the commercial, Medicare and Medicaid markets.
  • Key takeaways include:
    For 2022, leading health carriers comprised 38% for the commercial market and 22% for government lines.
  • Insights for this analysis were gleaned from MFA’s online database tool, Health Plans USA™ , an analytics tool for comparing market mix, market share and financial information about health plans, nationwide.

Stride, Inc. Announces the 2024 Career Connect Webinar Series to Help Students Explore Career Opportunities with National Employers

Retrieved on: 
Thursday, March 21, 2024

Stride, Inc., the nation’s leading provider of online and blended education programs, announced today that K12 will hold a 2024 Career Connect webinar series featuring industry-leading employers.

Key Points: 
  • Stride, Inc., the nation’s leading provider of online and blended education programs, announced today that K12 will hold a 2024 Career Connect webinar series featuring industry-leading employers.
  • Through these webinars, K12-powered students nationwide can learn about on-demand careers, explore career paths, and apply for internships and jobs.
  • Hiring managers and company representatives will discuss how to search, apply, and interview for job opportunities during each online event.
  • The 2024 Career Connect webinar series will be hosted on Pathful , a workforce readiness system that integrates college and career exploration, work-based learning, and employability platforms.

Diversity Research Institute to Honor Diversity First Top Companies for Diversity and their CEOs at the 20th Annual National Diversity & Leadership Conference in Dallas, TX

Retrieved on: 
Wednesday, March 13, 2024

The companies to be honored were selected from the U.S. Fortune 500 Governance Report (2023) published by Diversity First and DRI last year.

Key Points: 
  • The companies to be honored were selected from the U.S. Fortune 500 Governance Report (2023) published by Diversity First and DRI last year.
  • The report evaluates the executive and board demographics of U.S. Fortune 500 companies.
  • It assesses racial/ethnic and gender demographics of each company according to 2019 U.S. Census Data, providing each company with a score and a ranking.
  • The DRI, in affiliation with Diversity First, lists the companies with the highest scores as Diversity First Top 50 Companies.

AM Best Affirms Credit Ratings of Most of CVS Health Corporation’s Aetna Inc. Subsidiaries; Withdraws Credit Ratings of Members of Texas Health Aetna

Retrieved on: 
Wednesday, March 13, 2024

In addition, AM Best has affirmed the FSR of A (Excellent) and the Long-Term ICRs of “a” (Excellent) of Texas Health + Aetna Health Insurance Company, as well as Texas Health + Aetna Health Plan Inc.

Key Points: 
  • In addition, AM Best has affirmed the FSR of A (Excellent) and the Long-Term ICRs of “a” (Excellent) of Texas Health + Aetna Health Insurance Company, as well as Texas Health + Aetna Health Plan Inc.
  • Both companies are domiciled in Arlington, TX, and collectively are referred to as Texas Health Aetna.
  • At the same time, AM Best has withdrawn the ratings of Texas Health Aetna as the companies have requested to no longer participate in AM Best’s interactive rating process.
  • Aetna Life & Health Group has moderate reinsurance leverage and its reinsurance arrangements differentiates Aetna from its health insurance peers.

Berger Montague Announces that its False Claims Act Whistleblower Case Against CVS Health Will Move Forward to Trial

Retrieved on: 
Thursday, April 4, 2024

PHILADELPHIA, April 4, 2024 /PRNewswire/ -- Berger Montague PC is pleased to announce that its False Claims Act whistleblower case against CVS Caremark Corp. (including its pharmacy benefit manager subsidiary, CVS Caremark) for false drug pricing to Medicare will move forward to trial.

Key Points: 
  • PHILADELPHIA, April 4, 2024 /PRNewswire/ -- Berger Montague PC is pleased to announce that its False Claims Act whistleblower case against CVS Caremark Corp. (including its pharmacy benefit manager subsidiary, CVS Caremark) for false drug pricing to Medicare will move forward to trial.
  • The case is brought under the False Claims Act which allows private individuals to bring claims on behalf of the government to recover for fraud against the government.
  • In its summary judgment decision, the Court rejected the CVS Health defendants' attempt to have the claims dismissed without trial.
  • We are very pleased with the Court's ruling and look forward to presenting our case to a jury at trial," said Sorensen.

CVS Health® expands pharmacy tuition assistance and scholarship programs

Retrieved on: 
Wednesday, April 3, 2024

WOONSOCKET, R.I., April 3, 2024 /PRNewswire/ -- To support the next generation of pharmacists, CVS Health® (NYSE: CVS) today announced two new offerings for pharmacy students: an enhanced PharmD tuition assistance program for eligible CVS Pharmacy® interns and a new scholarship for students enrolled in pharmacy schools nationwide.

Key Points: 
  • Investing in the future of community pharmacy helps ease students' financial barriers and challenges, and promotes a stable and inclusive pharmacy workforce pipeline
    WOONSOCKET, R.I., April 3, 2024 /PRNewswire/ -- To support the next generation of pharmacists, CVS Health® (NYSE: CVS) today announced two new offerings for pharmacy students: an enhanced PharmD tuition assistance program for eligible CVS Pharmacy® interns and a new scholarship for students enrolled in pharmacy schools nationwide.
  • The CVS Health PharmD tuition assistance program is available to all eligible CVS Pharmacy interns and consists of a $20,000 award per year.
  • CVS Pharmacy will continue to advance the practice of pharmacy and provide more opportunities for students to enter this important area of health care."
  • In the fall, the program will be expanded to CVS Pharmacy interns in their final two years of pharmacy education, with $20,000 available for each year while working as an intern for CVS Pharmacy.

CVS Health to hold first quarter 2024 earnings conference call

Retrieved on: 
Monday, April 1, 2024

WOONSOCKET, R.I., April 1, 2024 /PRNewswire/ -- CVS Health (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, May 1st, 2024, at 8:00 a.m.

Key Points: 
  • WOONSOCKET, R.I., April 1, 2024 /PRNewswire/ -- CVS Health (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, May 1st, 2024, at 8:00 a.m.
  • ET to discuss first quarter 2024 financial results.
  • An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year.